S. Assmann

Statistics in Medicine · 2001–2002

A researcher in the Science corpus: 2 papers; trusts 2 researchers and is trusted by 2 researchers here, as inferred from the citation graph.

Whom S. Assmann trusts overall

Their strongest outbound trust, strongest first, inferred from their citations.

  1. David Moher

Who trusts S. Assmann overall

  1. Kosuke Imai
  2. Guha Balakrishnan

Papers from S. Assmann's perspective

Ordered by how strongly the researchers S. Assmann trusts endorse each paper. Same corpus, a different order for every researcher.

  1. Testing for baseline balance in clinical trials.
  2. Subgroup analysis and other (mis)uses of baseline data in clinical trials.
  3. The CONSORT statement: revised recommendations for improving the quality of reports of parallel group randomized trials (Annals of Internal Medicine)
  4. How vague is vague? A simulation study of the impact of the use of vague prior distributions in MCMC using WinBUGS
  5. CONSORT 2010 Explanation and Elaboration: updated guidelines for reporting parallel group randomised trials (British medical journal)
  6. Reducing waste from incomplete or unusable reports of biomedical research. (The Lancet)
  7. Principles of multilevel modelling. (International Journal of Epidemiology)
  8. A comparison of observational studies and randomized, controlled trials. (New England Journal of Medicine)
  9. Gastrointestinal toxicity with celecoxib vs nonsteroidal anti-inflammatory drugs for osteoarthritis and rheumatoid arthritis: the CLASS study: A randomized controlled trial. Celecoxib Long-term… (Journal of the American Medical Association (JAMA))
  10. Statistical considerations in the intent-to-treat principle. (Controlled Clinical Trials)

Their papers